GENTAUR Molecular Products.

Pubmed ID :29920520
Publication Date : //

Context-dependent expression of a conditionally-inducible form of active Akt.

Akt kinases are key signaling components in proliferation-competent and post-mitotic cells. Here, we sought to create a conditionally-inducible form of active Akt for both in vitro and in vivo applications. We fused a ligand-responsive Destabilizing Domain (DD) derived from E. coli dihydrofolate reductase to a constitutively active mutant form of Akt1, Akt(E40K). Prior work indicated that such fusion proteins may be stabilized and induced by a ligand, the antibiotic Trimethoprim (TMP). We observed dose-dependent, reversible induction of both total and phosphorylated/active DD-Akt(E40K) by TMP across several cellular backgrounds in culture, including neurons. Phosphorylation of FoxO4, an Akt substrate, was significantly elevated after DD-Akt(E40K) induction, indicating the induced protein was functionally active. The induced Akt(E40K) protected cells from apoptosis evoked by serum deprivation and was neuroprotective in two cellular models of Parkinson's disease (6-OHDA and MPP+ exposure). There was no significant protection without induction. We also evaluated Akt(E40K) induction by TMP in mouse substantia nigra and striatum after neuronal delivery via an AAV1 adeno-associated viral vector. While there was significant induction in striatum, there was no apparent induction in substantia nigra. To explore the possible basis for this difference, we examined DD-Akt(E40K) induction in cultured ventral midbrain neurons. Both dopaminergic and non-dopaminergic neurons in the cultures showed DD-Akt(E40K) induction after TMP treatment. However, basal DD-Akt(E40K) expression was 3-fold higher for dopaminergic neurons, resulting in a significantly lower induction by TMP in this population. Such findings suggest that dopaminergic neurons may be relatively inefficient in protein degradation, a property that could relate to their lack of apparent DD-Akt(E40K) induction in vivo and to their selective vulnerability in Parkinson's disease. In summary, we generated an inducible, biologically active form of Akt. The degree of inducibility appears to reflect cellular context that will inform the most appropriate applications for this and related reagents.

Authors : Park Soyeon , Burke Robert E , Kareva Tatyana , Kholodilov Nikolai , Aimé Pascaline , Franke Thomas F , Levy Oren , Greene Lloyd A ,

Related products :

Catalog number	Product name	Quantity
26-941	GTP-binding proteins are GTPases and function as molecular switches that can flip between two states active, when GTP is bound, and inactive, when GDP is bound. 'Active' in this context usually means	0.05 mg
BMDV10328	MMP 10, Stromelysin_2, ~57kD (pro form) & ~44kD (active form), Rabbit anti_Human; paraffin, IH	0.5 ml.
BMDV10349	MMP_3, Stromelysin_3, 54_59kD (pro form) & 44_49kD (active form), Rabbit anti_Human; WB_IP (denatured)	0.5 ml.
BMDV10194	MMP 10, Stromelysin_2, ~57kD (pro form) & ~44kD (active form), Clone IVC5, Mab anti_Human; WB_IP (native)_No IH	0.5 ml.
BMDV10323	MMP_7, Matrilysin (PUMP_1), ~28kD (pro form) & ~18kD (active form), Rabbit anti_Human; paraffin, IH	0.5 ml.
BMDV10192	MMP_7, Matrilysin (PUMP_1), ~28kD (pro form) & ~18kD (active form), Clone ID2, Mab anti_Human; paraffin, IH	0.5 ml.
BMDV10191	MMP_3, Stromelysin_3, 54_59kD (pro form) & 44_49kD (active form), Clone SL_1 ID3, Mab anti_Human; WB_IF (NO IH)	0.5 ml.
BMDV10195	MMP 13, Collagenase_3, ~60kD (pro form) & ~48kD (active form), Clone VIIIA2, Mab anti_Human, Mouse, Rabbit; paraffin, IH_IP (native)	0.5 ml.
BMDV10326	MMP 1, Collagenase_1, 52kD (unglycosylated) & 57kD (glycosylated) pro form, and 42kD (unglycosylated) & 47kD (glycoslyated) active form, Rabbit anti_Human, NO X w_Bovine; paraffin, IH_WB	0.5 ml.
orb80796	Human MAPK3 Active protein ERK1_MAPK3 Recombinant is highly active form produced by phosphorylation of the purified ERK1_MAPK3 in vitro with MEK1 is non-glycosylated polypeptide having a molecular mas	3
EGE-1400neo	LEXSinduce2 Expression Kit contains vector pLEXSY_I_neo2 for inducible cytosolic or secretory expression	1Kit
EGE-1410ble	LEXSinduce3 Expression Kit contains vector pLEXSY_I_ble3 for inducible cytosolic or secretory expression	1 Kit
EGE-1410neo	LEXSinduce3 Expression Kit contains vector pLEXSY_I_neo3 for inducible cytosolic or secretory expression	1 Kit
EGE-1410blecherry	LEXSinduce3 Expression Kit contains vector pLEXSY_I_blecherry3 for inducible cytosolic or secretory expression	1 Kit
EGE-1400neo	LEXSinduce2 Expression Kit contains vector pLEXSY_I_neo2 for inducible cytosolic or secretory expression	1 Kit
EGE-1400ble	LEXSinduce2 Expression Kit contains vector pLEXSY_I_ble2 for inducible cytosolic or secretory expression	1 Kit
EGE-1410neo	LEXSinduce3 Expression Kit contains vector pLEXSY_I_neo3 for inducible cytosolic or secretory expression	1 Kit
EGE-1400ble	LEXSinduce2 Expression Kit contains vector pLEXSY_I_ble2 for inducible cytosolic or secretory expression	1Kit
EGE-1410blecherry	LEXSinduce3 Expression Kit contains vector pLEXSY_I_blecherry3 for inducible cytosolic or secretory expression	1Kit
EGE-1410ble	LEXSinduce3 Expression Kit contains vector pLEXSY_I_ble3 for inducible cytosolic or secretory expression	1 Kit
GTX23234	MMP 11 (active form)	500 µl
DM393-05	MMP 11 (active form)	0,5 ml
DM393	MMP 11 (active form)	1 ml
DM393	MMP 11 (active form)	1 ml
DM393-05	MMP 11 (active form)	0,5 ml